litlas
ログインアカウント作成

Bruce L. Levine

1980–2025 年に発表

151
論文数
63,435
被引用数
103
h 指数
149
i10 指数

被引用数

Bruce L. Levine の年別被引用数1983 年: 被引用 1 件1985 年: 被引用 1 件1988 年: 被引用 1 件1990 年: 被引用 3 件1991 年: 被引用 6 件1992 年: 被引用 3 件1994 年: 被引用 2 件1995 年: 被引用 4 件1996 年: 被引用 26 件1997 年: 被引用 55 件1998 年: 被引用 86 件1999 年: 被引用 70 件2000 年: 被引用 73 件2001 年: 被引用 51 件2002 年: 被引用 71 件2003 年: 被引用 54 件2004 年: 被引用 55 件2005 年: 被引用 92 件2006 年: 被引用 112 件2007 年: 被引用 144 件2008 年: 被引用 104 件2009 年: 被引用 122 件2010 年: 被引用 122 件2011 年: 被引用 174 件2012 年: 被引用 245 件2013 年: 被引用 475 件2014 年: 被引用 435 件2015 年: 被引用 755 件2016 年: 被引用 855 件2017 年: 被引用 935 件2018 年: 被引用 1,331 件2019 年: 被引用 3,278 件2020 年: 被引用 4,033 件2021 年: 被引用 3,804 件2022 年: 被引用 3,217 件2023 年: 被引用 2,514 件2024 年: 被引用 3,634 件2025 年: 被引用 2,016 件2026 年: 被引用 53 件1984 年は被引用が無いため表示していません1986〜1987 年は被引用が無いため表示していません1989 年は被引用が無いため表示していません1993 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 7,369 件、この内訳の 33.9%中国: 引用元論文 2,917 件、この内訳の 13.4%ドイツ: 引用元論文 1,472 件、この内訳の 6.8%イギリス: 引用元論文 1,102 件、この内訳の 5.1%イタリア: 引用元論文 816 件、この内訳の 3.7%フランス: 引用元論文 712 件、この内訳の 3.3%カナダ: 引用元論文 568 件、この内訳の 2.6%スペイン: 引用元論文 534 件、この内訳の 2.5%スイス: 引用元論文 528 件、この内訳の 2.4%オーストラリア: 引用元論文 504 件、この内訳の 2.3%オランダ: 引用元論文 483 件、この内訳の 2.2%日本: 引用元論文 453 件、この内訳の 2.1%
0%33.9%その他 19.7%

機関

分野

  • Medicine68.7%
  • Immunology and Microbiology15.4%
  • Biochemistry, Genetics and Molecular Biology13%
  • Engineering1.4%
  • Neuroscience0.4%
  • Materials Science0.4%
  • その他0.7%

トピック

  • CAR-T cell therapy research20%
  • Immune Cell Function and Interaction8.1%
  • Immunotherapy and Immune Responses7.1%
  • Virus-based gene therapy research5.7%
  • Cancer Immunotherapy and Biomarkers4.4%
  • T-cell and B-cell Immunology3.7%
  • その他51%

共著者

全論文

検索で開く
  1. Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia

    著者: Shannon L. Maude, Theodore W. Laetsch, Jochen Buechner, Susana Rives, Michael Boyer, Henrique Bittencourt, Peter Bader, Michael R. Verneris, Heather E. Stefanski, Gary D. Myers, Muna Qayed, Barbara De Moerloose, Hidefumi Hiramatsu, Krysta Schlis, Kara L. Davis, Paul L. Martin, Eneida R. Nemecek, Gregory A. Yanik, Christina Peters, André Baruchel, Nicolas Boissel, Françoise Méchinaud, Adriana Balduzzi, Joerg Krueger, Carl H. June, Bruce L. Levine, Patricia A. Wood, Tetiana Taran, Mimi Leung, Karen T. Mueller, Yiyun Zhang, Kapildeb Sen, David Lebwohl, Michael A. Pulsipher, Stephan A. Grupp - New England Journal of Medicine 2018 被引用: 5,641

  2. Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia

    著者: Shannon L. Maude, Noelle V. Frey, Pamela A. Shaw, Richard Aplenc, David M. Barrett, Nancy Bunin, Anne Chew, Vanessa Gonzalez, Zhaohui Zheng, Simon F. Lacey, Yolanda D. Mahnke, J. Joseph Melenhorst, Susan R. Rheingold, Angela Shen, David T. Teachey, Bruce L. Levine, Carl H. June, David L. Porter, Stephan A. Grupp - New England Journal of Medicine 2014 被引用: 5,408

  3. Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia

    著者: Joseph A. Fraietta, Simon F. Lacey, Elena J. Orlando, Iulian Pruteanu-Malinici, Mercy Gohil, Stefan Lundh, Alina C. Boesteanu, Yan Wang, Roddy S. O’Connor, Wei‐Ting Hwang, Edward Pequignot, David E Ambrose, Changfeng Zhang, Nicholas S. Wilcox, Felipe Bedoya, Corin L. Dorfmeier, Chen Fang, Lifeng Tian, Harit Parakandi, Minnal Gupta, Regina M. Young, F. Brad Johnson, Irina Kulikovskaya, Li Liu, Jun Xu, Sadik H. Kassim, Megan M. Davis, Bruce L. Levine, Noelle V. Frey, Donald L. Siegel, Alexander C. Huang, E. John Wherry, Hans Bitter, Jennifer L. Brogdon, David L. Porter, Carl H. June, J. Joseph Melenhorst - Nature Medicine 2018 被引用: 1,770

  4. A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma

    著者: Donald M. O’Rourke, MacLean P. Nasrallah, Arati Desai, J. Joseph Melenhorst, Keith G. Mansfield, Jennifer J.D. Morrissette, Maria Martinez‐Lage, Steven Brem, Eileen Maloney, Angela Shen, Randi Isaacs, Suyash Mohan, Gabriela Plesa, Simon F. Lacey, Jean‐Marc Navenot, Zhaohui Zheng, Bruce L. Levine, Hideho Okada, Carl H. June, Jennifer L. Brogdon, Marcela V. Maus - Science Translational Medicine 2017 被引用: 1,772

  5. CRISPR-engineered T cells in patients with refractory cancer

    著者: Edward A. Stadtmauer, Joseph A. Fraietta, Megan M. Davis, Adam D. Cohen, Kristy Weber, Eric Lancaster, Patricia Mangan, Irina Kulikovskaya, Minnal Gupta, Fang Chen, Lifeng Tian, Vanessa Gonzalez, Jun Xu, In-Young Jung, J. Joseph Melenhorst, Gabriela Plesa, Joanne Shea, Tina Matlawski, Amanda Cervini, Avery L. Gaymon, Stephanie Desjardins, Anne Lamontagne, January Salas-McKee, Andrew D. Fesnak, Donald L. Siegel, Bruce L. Levine, Julie K. Jadlowsky, Regina M. Young, Anne Chew, Wei‐Ting Hwang, Elizabeth O. Hexner, Beatriz M. Carreno, Christopher L. Nobles, Frederic D. Bushman, Kevin R. Parker, Yanyan Qi, Ansuman T. Satpathy, Howard Y. Chang, Yangbing Zhao, Simon F. Lacey, Carl H. June - Science 2020 被引用: 1,484

  6. Decade-long leukaemia remissions with persistence of CD4+ CAR T cells

    著者: J. Joseph Melenhorst, Gregory M. Chen, Meng Wang, David L. Porter, Changya Chen, McKensie Collins, Peng Gao, Shovik Bandyopadhyay, Hongxing Sun, Ziran Zhao, Stefan Lundh, Iulian Pruteanu-Malinici, Christopher L. Nobles, Sayantan Maji, Noelle V. Frey, Saar Gill, Alison W. Loren, Lifeng Tian, Irina Kulikovskaya, Minnal Gupta, David E Ambrose, Megan M. Davis, Joseph A. Fraietta, Jennifer L. Brogdon, Regina M. Young, Anne Chew, Bruce L. Levine, Donald L. Siegel, Cécile Alanio, E. John Wherry, Frederic D. Bushman, Simon F. Lacey, Kai Tan, Carl H. June - Nature 2022 被引用: 947

  7. Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia

    著者: David L. Porter, Bruce L. Levine, Michael Kalos, Adam Bagg, Carl H. June - New England Journal of Medicine 2011 被引用: 3,541

  8. Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia

    著者: Stephan A. Grupp, Michael Kalos, David M. Barrett, Richard Aplenc, David L. Porter, Susan R. Rheingold, David T. Teachey, Anne Chew, Bernd Hauck, J. Fraser Wright, Michael C. Milone, Bruce L. Levine, Carl H. June - New England Journal of Medicine 2013 被引用: 3,491

  9. Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas

    著者: Stephen J. Schuster, Jakub Svoboda, Elise A. Chong, Sunita D. Nasta, Anthony R. Mato, Özlem Anak, Jennifer L. Brogdon, Iulian Pruteanu-Malinici, Vijay Bhoj, Daniel J. Landsburg, Mariusz A. Wasik, Bruce L. Levine, Simon F. Lacey, J. Joseph Melenhorst, David L. Porter, Carl H. June - New England Journal of Medicine 2017 被引用: 1,854

  10. Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells

    著者: Joseph A. Fraietta, Christopher L. Nobles, Morgan A. Sammons, Stefan Lundh, Shannon A. Carty, Tyler J. Reich, Alexandria P. Cogdill, Jennifer J.D. Morrissette, Jamie E. DeNizio, Shantan Reddy, Young Sun Hwang, Mercy Gohil, Irina Kulikovskaya, Farzana Nazimuddin, Minnal Gupta, Fang Chen, J.K. Everett, Katherine A. Alexander, Enrique Lin-Shiao, Marvin H. Gee, Xiaojun Liu, Regina M. Young, David E Ambrose, Yan Wang, Jun Xu, Martha S. Jordan, Katherine T. Marcucci, Bruce L. Levine, K. Christopher García, Yangbing Zhao, Michael Kalos, David Porter, Rahul M. Kohli, Simon F. Lacey, Shelley L. Berger, Frederic D. Bushman, Carl H. June, J. Joseph Melenhorst - Nature 2018 被引用: 873

  11. PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial

    著者: Vivek Narayan, Julie S. Barber-Rotenberg, In-Young Jung, Simon F. Lacey, Andrew J. Rech, Megan M. Davis, Wei‐Ting Hwang, Priti Lal, Erica L. Carpenter, Shannon L. Maude, Gabriela Plesa, Neha Vapiwala, Anne Chew, Michael Moniak, Ronnie Sebro, Michael D. Farwell, Amy Marshall, Joan Gilmore, Lester Lledo, Karen Dengel, S. Church, Tyler Hether, Jun Xu, Mercy Gohil, Thomas H. Buckingham, Stephanie S. Yee, Vanessa Gonzalez, Irina Kulikovskaya, Fang Chen, Lifeng Tian, Kyle Tien, Whitney L. Gladney, Christopher L. Nobles, Hayley E. Raymond, Prostate Cancer Cellular Therapy Program Investigators, Diane Frazee, Mary Truran, Elizabeth Veloso, Holly McConville, Jonathan Aguedelo, Samantha Hower, Sophia Ngo, Julie K. Jadlowsky, J. Joseph Melenhorst, Aoife M. Roche, J.K. Everett, Minnal Gupta, Farzana Nazimuddin, Chelsie Bartoszek, Natalka Koterba, Rachael Reynolds, Farris Ellington, Christopher C. Kloss, Ji‐Hyun Lee, Yangbing Zhao, John Scholler, James L. Riley, Christina Bailey, Andrew J. P. White, Briana M. Hudson, Pearl Chang, Marcela V. Maus, Bruce L. Levine, Elizabeth O. Hexner, Donald L. Siegel, Frederic D. Bushman, Carl H. June, Joseph A. Fraietta, Naomi B. Haas - Nature Medicine 2022 被引用: 500

  12. Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia

    著者: David Porter, Wei‐Ting Hwang, Noelle V. Frey, Simon F. Lacey, Pamela A. Shaw, Alison W. Loren, Adam Bagg, Katherine T. Marcucci, Angela Shen, Vanessa Gonzalez, David E Ambrose, Stephan A. Grupp, Anne Chew, Zhaohui Zheng, Michael C. Milone, Bruce L. Levine, J. Joseph Melenhorst, Carl H. June - Science Translational Medicine 2015 被引用: 1,727

  13. T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy

    著者: Guido Ghilardi, Joseph A. Fraietta, James N. Gerson, Vivianna M. Van Deerlin, Jennifer J.D. Morrissette, Gabriel C. Caponetti, Luca Paruzzo, Jaryse Harris, Elise A. Chong, Sandra P. Susanibar-Adaniya, Jakub Svoboda, Sunita D. Nasta, Ositadimma Ugwuanyi, Daniel J. Landsburg, Eugenio Fardella, Adam Waxman, Emeline R. Chong, Vrutti Patel, Raymone Pajarillo, Irina Kulikovskaya, David Lieberman, Adam D. Cohen, Bruce L. Levine, Edward A. Stadtmauer, Noelle V. Frey, Dan T. Vogl, Elizabeth O. Hexner, Stefan K. Barta, David L. Porter, Alfred L. Garfall, Stephen J. Schuster, Carl H. June, Marco Ruella - Nature Medicine 2024 被引用: 256

  14. T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia

    著者: Michael Kalos, Bruce L. Levine, David L. Porter, Sharyn I. Katz, Stephan A. Grupp, Adam Bagg, Carl H. June - Science Translational Medicine 2011 被引用: 2,403

  15. Unanswered questions following reports of secondary malignancies after CAR-T cell therapy

    著者: Bruce L. Levine, Marcelo C. Pasquini, John E. Connolly, David L. Porter, Michael P. Gustafson, Jaap Jan Boelens, Edwin M. Horwitz, Stephan A. Grupp, Marcela V. Maus, Frederick L. Locke, Fabio Ciceri, Annalisa Ruggeri, John A. Snowden, Helen E. Heslop, Crystal L. Mackall, Carl H. June, Anna M. Sureda, Miguel‐Angel Perales - Nature Medicine 2024 被引用: 196

  16. B cell maturation antigen–specific CAR T cells are clinically active in multiple myeloma

    著者: Adam D. Cohen, Alfred L. Garfall, Edward A. Stadtmauer, J. Joseph Melenhorst, Simon F. Lacey, Eric Lancaster, Dan T. Vogl, Brendan M. Weiss, Karen Dengel, Annemarie Nelson, Gabriela Plesa, Fang Chen, Megan M. Davis, Wei‐Ting Hwang, Regina M. Young, Jennifer L. Brogdon, Randi Isaacs, Iulian Pruteanu-Malinici, Don L. Siegel, Bruce L. Levine, Carl H. June, Michael C. Milone - Journal of Clinical Investigation 2019 被引用: 790

  17. Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic Leukemia

    著者: David T. Teachey, Simon F. Lacey, Pamela A. Shaw, J. Joseph Melenhorst, Shannon L. Maude, Noelle V. Frey, Edward Pequignot, Vanessa Gonzalez, Fang Chen, Jeffrey Finklestein, David M. Barrett, Scott L. Weiss, Julie C. Fitzgerald, Robert A. Berg, Richard Aplenc, Colleen Callahan, Susan R. Rheingold, Zhaohui Zheng, Stefan Rose‐John, Jason C. White, Farzana Nazimuddin, Gerald Wertheim, Bruce L. Levine, Carl H. June, David L. Porter, Stephan A. Grupp - Cancer Discovery 2016 被引用: 1,084

  18. Global Manufacturing of CAR T Cell Therapy

    著者: Bruce L. Levine, James Miskin, Keith Wonnacott, Christopher Hunt Keir - Molecular Therapy — Methods & Clinical Development 2017 被引用: 735

  19. Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma

    著者: Gerald P. Linette, Edward A. Stadtmauer, Marcela V. Maus, Aaron P. Rapoport, Bruce L. Levine, Lyndsey Emery, Leslie A. Litzky, Adam Bagg, Beatriz M. Carreno, Patrick J. Cimino, Gwendolyn Binder-Scholl, Dominic Smethurst, Andrew B. Gerry, Nick Pumphrey, Alan Bennett, Joanna E. Brewer, Joseph Dukes, Jane Harper, Helen K. Tayton-Martin, Bent K. Jakobsen, Namir J. Hassan, Michael Kalos, Carl H. June - Blood 2013 被引用: 1,163

  20. Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell

    著者: Marco Ruella, Jun Xu, David M. Barrett, Joseph A. Fraietta, Tyler J. Reich, David E Ambrose, Michael Klichinsky, Olga Shestova, Prachi Patel, Irina Kulikovskaya, Farzana Nazimuddin, Vijay Bhoj, Elena J. Orlando, Terry J. Fry, Hans Bitter, Shannon L. Maude, Bruce L. Levine, Christopher L. Nobles, Frederic D. Bushman, Regina M. Young, John Scholler, Saar Gill, Carl H. June, Stephan A. Grupp, Simon F. Lacey, J. Joseph Melenhorst - Nature Medicine 2018 被引用: 645

  21. Safety and Efficacy of Intratumoral Injections of Chimeric Antigen Receptor (CAR) T Cells in Metastatic Breast Cancer

    著者: Julia Tchou, Yangbing Zhao, Bruce L. Levine, Paul J. Zhang, Megan M. Davis, J. Joseph Melenhorst, Irina Kulikovskaya, Andrea Brennan, Xiaojun Liu, Simon F. Lacey, Avery D. Posey, Austin D. Williams, Alycia So, José R. Conejo-García, Gabriela Plesa, Regina M. Young, Shannon E. McGettigan, Jean S. Campbell, Robert H. Pierce, Jennifer M. Matro, Angela DeMichele, Amy S. Clark, Laurence J.N. Cooper, Lynn M. Schuchter, Robert H. Vonderheide, Carl H. June - Cancer Immunology Research 2017 被引用: 443

  22. Activity of Mesothelin-Specific Chimeric Antigen Receptor T Cells Against Pancreatic Carcinoma Metastases in a Phase 1 Trial

    著者: Gregory L. Beatty, Mark H. O’Hara, Simon F. Lacey, Drew A. Torigian, Farzana Nazimuddin, Fang Chen, Irina Kulikovskaya, Michael C. Soulen, Maureen McGarvey, Anne Marie Nelson, Whitney L. Gladney, Bruce L. Levine, J. Joseph Melenhorst, Gabriela Plesa, Carl H. June - Gastroenterology 2018 被引用: 500

  23. Mesothelin-Specific Chimeric Antigen Receptor mRNA-Engineered T Cells Induce Antitumor Activity in Solid Malignancies

    著者: Gregory L. Beatty, Andrew R. Haas, Marcela V. Maus, Drew A. Torigian, Michael C. Soulen, Gabriela Plesa, Anne Chew, Yangbing Zhao, Bruce L. Levine, Steven Μ. Albelda, Michael Kalos, Carl H. June - Cancer Immunology Research 2013 被引用: 860

  24. Phase I Study of Lentiviral-Transduced Chimeric Antigen Receptor-Modified T Cells Recognizing Mesothelin in Advanced Solid Cancers

    著者: Andrew R. Haas, János L. Tanyi, Mark H. O’Hara, Whitney L. Gladney, Simon F. Lacey, Drew A. Torigian, Michael C. Soulen, Lifeng Tian, Maureen McGarvey, Anne Marie Nelson, Caitlin S. Farabaugh, Edmund K. Moon, Bruce L. Levine, J. Joseph Melenhorst, Gabriela Plesa, Carl H. June, Steven Μ. Albelda, Gregory L. Beatty - Molecular Therapy 2019 被引用: 371